1. Dunn JT. Seven deadly sins in confronting endemiciodine deficiency, and how to avoid them. Endocrinol Metab 1996; 81: 1332–5.
2. Lazarus J, Obuobie K. Thyroid disorders – an update. Postgr Med J 2000; 76: 529–36.
3. Allen EM, Appel MC, Braverman LE. The effect of iodine ingestion on development of spontaneous lymphocytic thyroiditis in the diabetic-prone BB/ W rat. Endocrinology 1986; 28: 157–63.
4. Голицин С.П., Бакалов С.А., Сердюк С.Е. и др. Кардиальные и эндокринные аспекты применения амиодарона в современной практике лечения нарушений ритма сердца. Под. ред. Е.И.Чазова, И.И.Дедова. М., 2012.
5. Teng W, Shan Z, Teng X et al. Effect of iodine intake on thyroid diseases in China. Engl J Med 2006; 354: 2783–93.
6. Loh K. Amiodarone-induced thyroid disorders: a clinical review. Postgrad Med J 2000; 76: 133–40.
7. Iervasi G, Clerico A, Bonini R et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997; 82: 275–80.
8. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid 1998; 8: 101–6.
9. Burgi H, Schaffner TH, Seiler JP. The toxicology of iodate: a review of the literature. Thyroid 2001; 11: 449–56.
10. Robison LM, Sylvester PW, Birkenfeld P et al. Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Health 1998; 55: 93–106.
11. WHO. The 58th World Health Assembly WHA58.24:Sustaining the elimination of iodine deficiency disorders. WHA58_24-en.pdf (accessed Nov 18, 2007).
12. McConahey WM, Keatimg FR, Beahrs OH et al. On the increasing occurrence of Hashimoto thyroiditis. J Clin Endocrinol Metab 1962; 22: 542–4.
13. Vollenweider R, Stolkin I, Hedinger C. Fokale Lymphozytare Thyreoiditis und Jodsalzprophylaxe. Vergleichende Untersuchungen an Strumare-sektaten des Institutes fur Pathologie der Universitat Zurich. Schweiz Med Wsehr 1982; 112: 482–8.
14. Burgi H, Baumgarther H, Steiger G. Gibt es eine obere Vertraglichkeitsgrenze deralimentaren Jodzufuhr. Schweiz Med Wochenschr 1982; 112: 2–7.
15. Fenzi GF, Giani C, Ceccarelli P et al. Role of autoimmune, familial factors in goiter prevalence. Studies performed in moderately endemic area. J Clin Invest 1986; 9: 161–4.
16. Laurberg P, Pedersen KM, Hreidarsson A et al. Iodine intake
and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765–9.
17. Kampe O, Janson R, Karlsson A. Effect of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1990; 70: 1014–8.
18. Kessler JH. The effect of supraphysiologiclevelsof iodine on patients with cyclic mastalgia. Breast J 2004; 10: 328–36.
19. Платонова Н.М. Йододефицитные заболевания (профилактика, диагностика, лечение и мониторинг). Автореф. дис. ... д-ра мед. наук. М., 2010.
20. Azizi F, Hedayati M, Rahmani M et al. Reappraisal of the risk of iodineinduced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005; 28: 23–9.
Авторы
Ф.М.Абдулхабирова
ФГБУ Эндокринологический научный центр Минздрава России, Москва